Sep 07, 2022 / 12:50PM GMT
Ana BitetoGarg -
Well, good morning, everyone, and thank you for taking the time to join Citi's Annual Biopharma Conference. My name is Ana BitetoGarg. I'm one of the biotech analysts here at Citi. I'm very pleased to be joined for our next fireside chat by the management team from Amgen. So we have the company's CFO, Peter Griffith and we also have the company's Head of R&D, David Reese as well. And before we get into the discussion, if anybody does have any Q&A that you would like to ask, there may be an opportunity to do that towards the end. And with that, I want to thank both of you for being here. And I'll turn it over to you if you want to make any opening.
Peter H. Griffith - Amgen Inc. - Executive VP & CFO
Well, thank you, Nina. Great to see everybody in person. When we got in last night, we didn't quite know what the water was being from California. So it was nice to see a little bit of rain and get a little bit of cool weather it's been quite hot in California. So delighted to be here. And we'd like to thank Citi and we'd like to thank you for the
Amgen Inc at Citi BioPharma Conference Transcript
Sep 07, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers